Evogliptin HCl - CAS 1246960-27-9

Evogliptin (DA-1229) is a potent and selective DPP4 inhibitor (dipeptidyl peptidase 4 inhibitor) that can improve insulin resistance and delays the onset of diabetes. Evogliptin delays the onset of diabetes in young db/db mice and improves insulin sensitivity in HF mice.

Others, Proteasome

Proteases/Proteasome, Ubiquitination, Others

1246924

C19H27ClF3N3O3

437.88

C(C[C@@H](CC1=C(F)C=C(F)C(F)=C1)N)(=O)N2[C@H](COC(C)(C)C)C(=O)NCC2.Cl

-20°C

Ice Packs

Small Compound